Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Schuler

Showing results (1-10 of 296) with videos related to

Pageof 30
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2025
Facts and Hopes in Neoadjuvant Immunotherapy Combinations in Resectable Non-Small Cell Lung CancerMartin Schuler
The Lancet. Oncology|October 30, 2020
The quest for efficient trial designs in precision oncologyMartin Schuler
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|May 14, 2013
[Medical care of the cancer patient - Is it really so different?]Martin Schuler
Future Oncology (London, England)|April 24, 2014
LUX-Lung 3: redundancy, toxicity or a major step forward? Afatinib as front-line therapy for patients with metastatic EGFR-mutated lung cancerJens Köhler, Martin Schuler
Onkologie|September 21, 2013
Afatinib, erlotinib and gefitinib in the first-line therapy of EGFR mutation-positive lung adenocarcinoma: a reviewJens Köhler, Martin Schuler
Leukemia & Lymphoma|April 18, 2009
Molecular mechanisms of resistance to Rituximab and pharmacologic strategies for its circumventionClaudia Stolz, Martin Schuler
European Journal of Cancer (Oxford, England : 1990)|February 6, 2014
Targeted therapies in gastroesophageal cancerStefan Kasper, Martin Schuler
Current Drug Targets|November 1, 2006
Therapeutic targeting of apoptotic pathways in cancerJohannes Meiler, Martin Schuler
European Journal of Cancer (Oxford, England : 1990)|January 9, 2021
Shall we use steroids when treating patients with lung cancer with checkpoint inhibitors?Niels Reinmuth, Martin Schuler
Expert Review of Anticancer Therapy|August 3, 2011
Polo-like kinase 1 inhibitors in mono- and combination therapies: a new strategy for treating malignanciesDaniel C Christoph, Martin Schuler
Pageof 30

Showing results (1-10 of 296) with videos related to

Sort By:
Pageof 30
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2025
Facts and Hopes in Neoadjuvant Immunotherapy Combinations in Resectable Non-Small Cell Lung CancerMartin Schuler
The Lancet. Oncology|October 30, 2020
The quest for efficient trial designs in precision oncologyMartin Schuler
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|May 14, 2013
[Medical care of the cancer patient - Is it really so different?]Martin Schuler
Future Oncology (London, England)|April 24, 2014
LUX-Lung 3: redundancy, toxicity or a major step forward? Afatinib as front-line therapy for patients with metastatic EGFR-mutated lung cancerJens Köhler, Martin Schuler
Onkologie|September 21, 2013
Afatinib, erlotinib and gefitinib in the first-line therapy of EGFR mutation-positive lung adenocarcinoma: a reviewJens Köhler, Martin Schuler
Leukemia & Lymphoma|April 18, 2009
Molecular mechanisms of resistance to Rituximab and pharmacologic strategies for its circumventionClaudia Stolz, Martin Schuler
European Journal of Cancer (Oxford, England : 1990)|February 6, 2014
Targeted therapies in gastroesophageal cancerStefan Kasper, Martin Schuler
Current Drug Targets|November 1, 2006
Therapeutic targeting of apoptotic pathways in cancerJohannes Meiler, Martin Schuler
European Journal of Cancer (Oxford, England : 1990)|January 9, 2021
Shall we use steroids when treating patients with lung cancer with checkpoint inhibitors?Niels Reinmuth, Martin Schuler
Expert Review of Anticancer Therapy|August 3, 2011
Polo-like kinase 1 inhibitors in mono- and combination therapies: a new strategy for treating malignanciesDaniel C Christoph, Martin Schuler
Pageof 30